Consolidation treatment with yttrium-90 ibritumomab tiuxetan after new induction regimen in advanced stage follicular lymphoma: update results from the Spanish Lymphoma Oncology Group trial after a median follow-up of 8.5-years
- Provencio, M. 1
- Franco, F. 1
- Gómez-Codina, J. 2
- Quero Blanco, C. 3
- Llanos, M. 4
- Garcia-Arroyo, F. 5
- de la Cruz, L. 6
- Gumá, J. 7
- Delgado, J.R. 8
- Álvarez, R. 9
- Chacón, J.I. 9
- Royuela, A. 10
- Rueda, A. 11
-
1
Hospital Universitario Puerta de Hierro
info
-
2
Hospital Universitario La Fe
info
- 3 Hospital Clinico de Malaga
-
4
Hospital Universitario Nuestra Señora de Candelaria
info
Hospital Universitario Nuestra Señora de Candelaria
Santa Cruz de Tenerife, España
- 5 Department of Medical Oncology, Hospital de Pontevedra
-
6
Hospital Universitario Virgen Macarena
info
- 7 Department of Medical Oncology, Hospital Universitario de Reus
-
8
Hospital Universitario Virgen de las Nieves
info
-
9
Complejo Hospitalario de Toledo
info
- 10 Department of Biostatistic, Hospital Universitario Puerta del Hierro Majadahonda
-
11
Hospital Costa Del Sol
info
Revue:
Leukemia and Lymphoma
ISSN: 1029-2403
Année de publication: 2019
Volumen: 60
Número: 3
Pages: 856-859
Type: Lettre
La source de données: Scopus